A Trial of CRD-4730 in HFrEF
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 525 participants.
Also called NCT07750873
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 525 participants
- Registry
-
NCT07750873
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT07750873. Randomized; triple masking; primary purpose treatment. Start 2026-07-15 (actual); primary completion 2028-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Trial of CRD-4730 in HFrEF
- Acronym
- CALIBRATE-HF
- Intervention (Drug)
- CRD-4730
- Intervention (Drug)
- Placebo
- Lead sponsor
- Cardurion Pharmaceuticals, Inc.
Record details
- Record id
cardio:ct-nct07750873- Content hash
af90b7b9eb3e65e8d156c26be3344af0f6816ed88254ad84f85dab636e0d4f98